OZ BIOSCIENCES, THE ART OF TRANSFECTION
Since 2003, OZ Biosciences creates, develops and produces innovative molecular delivery systems specialized in transfection and transduction tools, for the worldwide scientific community and pharmaceutical industry. OZ Biosciences is focused on delivery technologies of biomolecules such as DNA, RNA and protein for in vitro and in vivo applications.
These past years, the life sciences have gone through a technological revolution. The progress achieved in genomic, functional genomic and proteomic areas has created fabulous opportunities for better understanding of basic biological processes and for the development of the next generation of medicines.
*Our Research & Development (R&D) department is composed of experts in : Organic chemistry, Inorganic chemistry (materials, nanoparticles,…), Polymer chemistry, Molecular Biology, Cellular Biology & Virology.
Our mission is to provide cutting-edge transfection and transduction reagents in order to enable life sciences researchers to achieve outstanding success. The company has established a strong position in the field of molecular delivery system with several patents and know-how for Magnetofection™, Magneto-biolisitic, magnetic-assisted transduction, Polyfection, Lipofection and 3D transfection, technologies.
OZ Biosciences has developed comprehensive lines of products:
1. Magnetofection™: a unique gene delivery method for in vitro and in vivo applications.
2. Lipofection: proprietary biodegradable lipid-based transfection reagents.
3. Transduction tools: for producing, concentrating, storing and enhancing virus efficiency.
4. 3D transfection: allowing nucleic acid delivery directly into 3D matrix.
5. Protein delivery systems: including antibody & based on biodegradable lipid nanoparticles.
6. Cell specific reagents: For specific cells such as neurons and stem cells.
7. Vaccine Adjuvants: Standard & novel adjuvants for antigenic & genetic immunization
OZ Biosciences is located in Marseille - France and San Diego - USA. The French headquarter is based in the Luminy Scientific Park and the US branch is located in a Business Park near the heart of important biological research activities. The company was founded by three internationally recognized experts in molecular delivery systems, gene therapy and vaccines: Olivier Zelphati, Christian Plank and Jean Haensler. OZ Biosciences team is composed by experienced and proficient scientists in the area of molecular delivery systems. Our expertise in molecular delivery systems especially transfection is allowing us to collaborate with academic and industrial research laboratories. The company has received several prestigious national and international awards.
AWARDED EUROPEAN GRANTS
- FP6: Improved precision of nucleic acid based therapy of cystic fibrosis. LSHB-CT-2004-005213.
- FP6: Combined isolation and stable non-viral transfection of hematopoietic cells – a novel platform technology for ex vivo hematopoietic stem cell gene therapy. LSHB-CT-2006-019038.
- FP6: Functional genomics and neurobiology of epilepsy: a basis for new therapeutic strategies. LSHM-CT-2006-037315.
- FP6: European Network for the advancement of Clinical Gene Transfer & Therapy. LSHB-CT-2006-018933.
- FP7: Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis. NMP3-SL-2010-245993.
- FP7: A “Universal” Influenza Vaccine through Synthetic, Dendritic Cell-Targeted, Self-Replicating RNA Vaccines. HEALTH-F3-2013-601738
- MODIFY-NK: A novel modified natural killer (NK) cell immunotherapy for the treatment of solid tumours. Eurostars.
REGISTERED TRADE MARKS FOR OUR TRANSFECTION REAGENTS
|
Magnetofection Transfection reagents |
Lipofection Transfection reagents |
| Magnetofection™ | Lullaby™ |
| Magnetofectamine™ | DreamFect™ |
| Mag4C™ | FlyFectin™ |
| i-MICST™ | DeliverIN™ |
| Hype™ | |
| 3D-FectIN™ | |
| 3D-Fect™ | |
| RmesFect™ |